BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3587880)

  • 1. Scintimetric detection of choroidal malignant melanoma with [123I]-5-iodo-2-thiouracil.
    Franken NA; van Delft JL; van Langevelde A; Bleeker JC; de Wolff-Rouendaal D; van Best JA; Bouwhuis-Hoogerwerf ML; Oosterhuis JA; Pauwels EK
    Ophthalmologica; 1986; 193(4):248-54. PubMed ID: 3587880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radio-iodine-labelled 5-iodo-2-thiouracil: a potential radiopharmaceutical for establishing the viability of ocular melanoma after radiation therapy.
    Franken NA; Van Langevelde A; Pauwels EK; Journée-de Korver JG; Bakker CN; Oosterhuis JA
    Nucl Med Commun; 1986 Nov; 7(11):797-809. PubMed ID: 3554049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of 123I-5-iodo-2-thiouracil, a possible radiopharmaceutical for noninvasive detection of ocular melanoma, in melanotic and amelanotic melanomas in hamsters.
    Franken NA; Van Langevelde A; Journée-De Korver JG; Bakker CN; Feitsma RI; Van Delft JL; Oosterhuis JA; Pauwels EK
    Nucl Med Commun; 1985 Oct; 6(10):657-63. PubMed ID: 4088550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct electrophilic iodination of 2-thiouracil using Iodo-Gen.
    Coderre JA; Halle DA
    Int J Rad Appl Instrum A; 1989; 40(9):759-63. PubMed ID: 2559065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.
    van Langevelde A; Bakker CN; Broxterman HJ; Journée-de Korver JG; Kaspersen FM; Oosterhuis JA; Pauwels EK
    Eur J Nucl Med; 1983; 8(2):45-51. PubMed ID: 6840126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential radioactivity monitor for noninvasive detection of ocular melanoma.
    Lambrecht RM; Packer S; Atkins HL
    Nucl Med Commun; 1984 Jun; 5(6):381-6. PubMed ID: 6531153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.
    Bockslaff H; Spitznas M; Hahn I; Kloster G
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):255-66. PubMed ID: 6915722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential radiopharmaceuticals for the detection of ocular melanoma. Part II. Iodoquinoline derivatives and 67Ga-citrate.
    van Langevelde A; Bakker CN; Boer H; Ilmer TA; Journée-de Korver JA; Kaspersen FM; Noach EL; Oosterhuis JA; Pauwels EK
    Eur J Nucl Med; 1986; 12(2):96-104. PubMed ID: 3460807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of ocular melanoma with 4-(3-dimethylaminopropylamino)-7-[123I]-iodoquinoline.
    Lambrecht RM; Packer S; Wolf AP; Lloyd D; Atkins HL
    J Nucl Med; 1984 Jul; 25(7):800-4. PubMed ID: 6737079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.
    Bockslaff H; Kloster G; Dausch D; Schad K; Hundeshagen H
    Graefes Arch Clin Exp Ophthalmol; 1982; 219(3):149-54. PubMed ID: 7173627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical role of N-isopropyl-p-[123I]-iodoamphetamine single photon emission computed tomography in the follow-up of choroidal melanoma after radiotherapy.
    Sou R; Oku N; Ohguro N; Hibino S; Fujikado T; Tano Y
    Jpn J Ophthalmol; 2004; 48(1):54-8. PubMed ID: 14767652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma.
    Schaling DF; van Kroonenburgh MJ; Borsje RA; Camps JA; Kakebeeke-Kemme HM; Oosterhuis JA; Pauwels EK
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(3):291-4. PubMed ID: 2500385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor detection with radiopharmaceuticals.
    Packer S
    Semin Nucl Med; 1984 Jan; 14(1):21-30. PubMed ID: 6369546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical assessment of 67Ga-citrate tumor scintigraphy in malignant melanoma].
    Kosuda S; Takagi Y; Kubo A; Sanmiya T; Okano Y; Hashimoto S; Nishikawa T
    Kaku Igaku; 1984 Jul; 21(7):781-90. PubMed ID: 6593478
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of choroidal malignant melanoma in which 123I-IMP scintigraphy was useful for diagnosis].
    Kotake F; Kawanishi M; Ishii I; Akata S; Kakizaki D; Abe K
    Kaku Igaku; 1998 Jul; 35(6):427-33. PubMed ID: 9753922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of [131I]thiouracil in tumours of patients with disseminated malignant melanoma. A pilot study.
    Olander K; Larsson BS; Ringborg U; Schnell PO
    Melanoma Res; 1992; 1(5-6):391-5. PubMed ID: 1422195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive phosphorus uptake test for the diagnosis of malignant melanoma of the choroid.
    Shields JA; Packer S
    Semin Nucl Med; 1984 Jan; 14(1):31-4. PubMed ID: 6710164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioactive phosphorus uptake test in ophthalmology].
    Honrubia FM; Navarro A; Abad MP; Albalad E; Olivan JM
    J Fr Ophtalmol; 1982; 5(10):579-83. PubMed ID: 7153462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of radioactive phosphorus (32P) uptake test in comparable sized choroidal melanomas and hemangiomas.
    Lanning R; Shields JA
    Am J Ophthalmol; 1979 Jun; 87(6):769-72. PubMed ID: 453306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodothiouracil as a melanoma localizing agent.
    Coderre JA; Packer S; Fairchild RG; Greenberg D; Laster B; Micca P; Fand I
    J Nucl Med; 1986 Jul; 27(7):1157-64. PubMed ID: 3723191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.